Cryo Cell International (CCEL) Raw Materials (2015 - 2016)
Cryo Cell International (CCEL) posted quarterly Raw Materials of $9100.0 for Q4 2016, up 0.65% year-over-year from $9041.0 in Q4 2015, and down 36.04% quarter-over-quarter from $14228.0 in Q3 2016.
Cryo Cell International (CCEL) Raw Materials (2015 - 2016) Analysis & Trends
Cryo Cell International (CCEL) has reported Raw Materials for 2 consecutive years, with $9100.0 the latest figure, recorded in Q4 2016.
- In Q4 2016, Raw Materials rose 0.65% year-over-year to $9100.0; the TTM figure through Nov 2016 stood at $9100.0 (up 0.65% YoY), while the FY2016 annual figure was $9100.0, up 0.65% from the prior year.
- Raw Materials eased to $9100.0 in Q4 2016 per CCEL's latest filing, from $14228.0 in the prior quarter.
- Across five years, Raw Materials topped out at $14228.0 in Q1 2016 and bottomed at $1751.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2016 | 9,100.00 |
| Aug 31, 2016 | 14,228.00 |
| May 31, 2016 | 14,228.00 |
| Feb 29, 2016 | 14,228.00 |
| Nov 30, 2015 | 9,041.00 |
| Aug 31, 2015 | 1,751.00 |